Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 13,815 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 13,815 shares of the company’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $16.89, for a total value of $233,335.35. Following the completion of the transaction, the chief financial officer now owns 1,482,595 shares in the company, valued at $25,041,029.55. This represents a 0.92 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Stock Performance

ALHC stock traded up $0.45 during midday trading on Wednesday, hitting $17.19. 2,791,742 shares of the company traded hands, compared to its average volume of 1,412,390. The business has a 50 day simple moving average of $14.68 and a 200-day simple moving average of $12.59. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of -22.32 and a beta of 1.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $17.41.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Barclays increased their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a report on Friday, February 28th. JPMorgan Chase & Co. increased their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Stephens restated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. Finally, Bank of America increased their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. R Squared Ltd acquired a new stake in shares of Alignment Healthcare in the fourth quarter worth $55,000. RiverPark Advisors LLC acquired a new stake in shares of Alignment Healthcare in the fourth quarter worth $106,000. Tower Research Capital LLC TRC grew its stake in shares of Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after acquiring an additional 6,286 shares during the last quarter. Ballentine Partners LLC acquired a new stake in shares of Alignment Healthcare in the fourth quarter worth $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Alignment Healthcare in the third quarter worth $131,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.